BJ’s Restaurant & Brewhouse® Raises Awareness and Funds to Fight Alzheimer’s With a Free Pizookie® Day on June 21
BJ’s Restaurant & Brewhouse joins the Alzheimer’s Association® to honor those living with Alzheimer’s and their caregivers on June 21
HUNTINGTON BEACH, Calif., June 20, 2018 (GLOBE NEWSWIRE) -- BJ’s Restaurants, Inc. (NASDAQ:BJRI) has joined the Alzheimer’s Association® as the proud Presenting Sponsor of The Longest Day, a day about love dedicated to all those affected by the Alzheimer’s disease. BJ’s Restaurant & Brewhouse will also be providing visibility to the cause in restaurants during June, Alzheimer’s & Brain Awareness Month, to invite guests, team members, friends and community to get involved.
Throughout June, BJ’s guests who donate a minimum of $1, at the end of their meal, to the Alzheimer’s Association will get a FREE Pizookie® on their next visit. On The Longest Day, Thursday, June 21, 2018, guests will receive a FREE Pizookie® with any $9.95 food purchase. Additionally, for every Pizookie® dessert ordered on June 21, 2018, BJ’s will donate $0.25 to the Alzheimer’s Association.
Held annually on the summer solstice, The Longest Day symbolizes the challenging journey of those living with Alzheimer’s disease and their caregivers. Participants will do what they love–biking, hiking, playing bridge, swimming, knitting and more–to honor a caregiver, someone living with Alzheimer’s, or someone lost to this devastating disease. Together, participants will raise funds and awareness to advance Alzheimer’s Association care, support and research programs.
Key facts about Alzheimer’s include:
- Worldwide, there are an estimated 47 million people living with Alzheimer's and other dementias and it is the nation’s sixth leading cause of death.
- More than five million Americans are living with Alzheimer’s and this national number is estimated to grow to as many as 14 million by year 2050.
- Additionally, there are more than 16 million Alzheimer’s caregivers, according to the Alzheimer’s Association 2018 Alzheimer’s Disease Facts and Figuresreport.
To learn more about The Longest Day and FREE Pizookie® visit: www.alz.org/bjs
About BJ’s Restaurants, Inc.
BJ’s Restaurants, Inc. currently owns and operates 200 casual dining restaurants under the BJ’s Restaurant & Brewhouse®, BJ’s Restaurant & Brewery®, BJ’s Pizza & Grill® and BJ’s Grill® brand names. BJ’s Restaurants offer an innovative and broad menu featuring award-winning, signature deep dish pizza complemented with generously portioned salads, appetizers, sandwiches, soups, pastas, entrees and desserts, including the Pizookie® dessert. Quality, flavor, value, moderate prices and sincere service remain distinct attributes of the BJ’s experience. All restaurants feature BJ’s critically acclaimed proprietary craft beers, which are produced at several of the Company’s Restaurant & Brewery locations, its two brewpubs in Texas and by independent third party craft brewers. The Company’s restaurants are located in the 27 states of Alabama, Arizona, Arkansas, California, Colorado, Florida, Indiana, Kansas, Kentucky, Louisiana, Maryland, Michigan, Nevada, New Jersey, New Mexico, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, Tennessee, Texas, Virginia and Washington. Visit BJ’s Restaurants, Inc. on the Web at http://www.bjsrestaurants.com for locations and additional information.
About the Alzheimer’s Association®
The Alzheimer’s Association is the leading voluntary health organization in Alzheimer's care, support and research. Our mission is to eliminate Alzheimer’s disease through the advancement of research, to provide and enhance care and support for all affected, and to reduce the risk of dementia through the promotion of brain health. Our vision is a world without Alzheimer’s. Visit alz.org or call 800.272.3900.
Media Contacts:
BJ’s Restaurant & Brewhouse
Lauren Collins, 714-500-2451
lcollins@bjsrestaurants.com
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/2c1f071a-0af9-437d-af4f-abb05b054931
© 2018 GlobeNewswire, Inc. All Rights Reserved.
U.S. FDA Approves Gilead Sciences' (Nasdaq: GILD) Antiviral Veklury (remdesivir) for the Treatment of COVID-19
